DUNAD THERAPEUTICS LTD – Trademark Portfolio

Entity Type: 16

DUNAD THERAPEUTICS LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DUNAD. The owner is based in CAMBRIDGE.

30 BROAD STREET

CAMBRIDGE CB23 6HJ

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DUNAD
DUNAD
Registered 2020

Trademark Classifications

DUNAD THERAPEUTICS LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does DUNAD THERAPEUTICS LTD have?

DUNAD THERAPEUTICS LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DUNAD THERAPEUTICS LTD file in?

DUNAD THERAPEUTICS LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are DUNAD THERAPEUTICS LTD's most well-known trademarks?

DUNAD THERAPEUTICS LTD's registered trademark portfolio includes well-known marks such as DUNAD. These are among 1 currently registered trademark in the portfolio.

What is DUNAD THERAPEUTICS LTD's trademark registration success rate?

DUNAD THERAPEUTICS LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.